PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $38,000 | -11.6% | 4,400 | +8.6% | 0.00% | – |
| Q3 2019 | $43,000 | +65.4% | 4,051 | +97.1% | 0.00% | – |
| Q2 2019 | $26,000 | -56.7% | 2,055 | +32.2% | 0.00% | – |
| Q1 2019 | $60,000 | +252.9% | 1,554 | +85.0% | 0.00% | – |
| Q4 2018 | $17,000 | -69.6% | 840 | -31.1% | 0.00% | -100.0% |
| Q3 2018 | $56,000 | +300.0% | 1,220 | +404.1% | 0.00% | – |
| Q2 2018 | $14,000 | -17.6% | 242 | -2.4% | 0.00% | – |
| Q1 2018 | $17,000 | -56.4% | 248 | -37.4% | 0.00% | -100.0% |
| Q4 2017 | $39,000 | +2.6% | 396 | +23.4% | 0.00% | 0.0% |
| Q3 2017 | $38,000 | +1166.7% | 321 | +903.1% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 32 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -93.8% | 32 | -94.0% | 0.00% | – |
| Q4 2016 | $16,000 | +700.0% | 532 | +1137.2% | 0.00% | – |
| Q3 2016 | $2,000 | – | 43 | +95.5% | 0.00% | – |
| Q2 2016 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |